Financial Organogenesis Holdings Inc. Reports Third Quarter and Nine Months of 2019 Financial Results byJosh SandbergNovember 13, 2019
Extremities Organogenesis Comparative Effectiveness Research Demonstrating Faster VLU Time to Healing with Apligraf® Showcased at ISPOR byJosh SandbergMay 31, 2018
Biologics Organogenesis Showcases New Product Offerings and Research at SAWC Spring 2018 byJosh SandbergApril 24, 2018
Biologics Top Stories Organogenesis Names New Chief Commercial Officer and Chief Operating Officer byJosh SandbergSeptember 19, 2017
Biologics Extremities PuraPly™ Antimicrobial Named One of Top 10 Innovations in Podiatry byJosh SandbergJuly 13, 2017
Biologics Financial Top Stories Organogenesis Closes on a $20 Million Facility from Eastward Capital Partners byJosh SandbergMay 23, 2017
Biologics Top Stories Organogenesis Inc. Announces Acquisition of NuTech Medical byJosh SandbergMarch 28, 2017
Financial Organogenesis Secures $30 Million in Financing to Fund Aggressive Expansion of Commercial Operations and Product Portfolio byJosh SandbergApril 15, 2016
